Chromosome 1q41-q42 deletion syndrome is a chromosomal anomaly that primarily affects development, leading to severe global developmental delay and intellectual disability along with distinctive facial features and other systemic complications. Affected individuals often present with neurological manifestations such as seizures and brain anomalies, as well as physical features including cleft palate, clubfeet, and nail hypoplasia. This condition is recognized as sporadic and follows an autosomal dominant pattern, typically presenting as isolated cases. Although precise prevalence estimates are not available, the condition is considered very rare.

The clinical features of chromosome 1q41-q42 deletion syndrome are multi-system in nature. Neurologically, individuals exhibit severe global developmental delay, intellectual disability, and seizures, which are central to the condition. Characteristic facial dysmorphism, including frontal bossing, anteverted nares, depressed nasal bridge, and hypertelorism, is noted along with short stature and growth delay. Additional findings such as neonatal hypotonia, cleft palate, and clubfeet are common, while other features like sparse eyebrows, small nails, and atypical behavior appear in a subset of cases. Not all individuals experience all features, and severity varies considerably.

The condition arises from a deletion in a specific region of chromosome 1 (q41-q42), and although no specific genes have been identified in the provided data, the alteration disrupts normal developmental processes. It occurs sporadically in affected individuals and follows an autosomal dominant pattern, which means that the deletion usually appears as a new event rather than being inherited from a parent. Families are encouraged to seek genetic counseling to understand potential recurrence risks and to discuss family planning options.